As President of the Virginia Chapter of the American Society of Addiction Medicine (VASAM), I strongly endorse the evidence-based proposal to allow buprenorphine prescribing to minors under the age of 16 and remove burdensome documentation requirements to prescribe buprenorphine at daily doses higher than 24 mg.